Latest Us Army News

Page 1 of 5
Vitrafy says it has moved from cryopreservation research into commercial execution, with 19 Guardion devices built, new US partnerships and $38.3 million in cash and term deposits. The next test is converting partner evaluations into recurring revenue after a planned FDA Class II listing in the coming weeks.
Victor Sage
Victor Sage
17 Nov 2026
Li-S Energy says its lithium-sulfur technology moved closer to commercialisation in 2026, with new Power Cells, defence testing and a nearly two-hour drone flight. The company is now planning the next manufacturing step while holding $15.0 million in cash.
Victor Sage
Victor Sage
10 Nov 2026
Metal Powder Works has secured its first Zircaloy-4 orders from Oak Ridge National Laboratory, the US Army Research Laboratory and an unnamed defence company. The immediate revenue is modest, but the evaluation work places MPW’s zirconium powders before strategically important US customers.
Victor Sage
Victor Sage
5 Nov 2026
Eden Innovations opened FY27 with US sales more than doubling to US$381,612, led by a sharp rise in OptiBlend orders and expanding EdenCrete plant installations. The company ended September with A$4.3 million in cash and no third-party debt, but still used A$892,000 in operating cash during the quarter.
Victor Sage
Victor Sage
30 Oct 2026
Metal Powder Works has secured its first multi-year order, lifting backlog to approximately A$1.3 million and bringing forward its 800-tonne annual capacity target. The commercial progress comes with a sharper funding question, as quarterly operating cash outflow reached A$3.3 million against A$6.9 million of cash.
Victor Sage
Victor Sage
30 Oct 2026
Li-S Energy has delivered its lithium-sulfur Power Cells to a US Army research centre and completed a near two-hour endurance flight with its Pegasus drone. The milestones advance its defence and aerospace commercialisation pipeline, but neither has yet produced a procurement order or confirmed revenue.
Victor Sage
Victor Sage
29 Oct 2026
Elsight delivered US$25.8 million in unaudited revenue for the first nine months of 2026, up 91% on the prior corresponding period, but a weaker-than-expected third quarter produced a non-GAAP loss. The company is relying on expanded US defence procurement access, new products and a US$196 million opportunity pipeline to support future growth.
Victor Sage
Victor Sage
28 Oct 2026
Savana US Small Caps Active ETF (ASX:SVNP) fell 7.65% in September, trailing the S&P SmallCap 600 by 4.92 percentage points as higher US bond yields and a concentrated AI rally split the market. The manager says its valuation discipline kept it away from the month’s strongest semiconductor performers, while highlighting a 52% gain from its Everforth investment.
Claire Turing
Claire Turing
6 Oct 2026
Eden Innovations reported a sharp acceleration in US sales during Q1 FY27, led by a 247% jump in OptiBlend revenue and expanding EdenCrete plant installations. The figures are unaudited management results, but they give the company a stronger opening quarter for the new financial year.
Victor Sage
Victor Sage
6 Oct 2026
Li-S Energy says its Geelong lithium-sulfur production line is complete and has delivered 10Ah Power Cells to the US Army for testing. The company is targeting its first commercial battery sale in 2027, while holding A$15.6 million in cash and investments and A$9.3 million in secured grants yet to be received.
Victor Sage
Victor Sage
16 Sept 2026
Li-S Energy has inked a strategic collaboration with Australian defence firm EPE, unlocking pathways to international defence markets for its ultra-lightweight lithium sulfur batteries.
Victor Sage
Victor Sage
2 Sept 2026
Island Pharmaceuticals has obtained regulatory rights to reference critical Marburg-Angola virus natural history data, clearing a significant FDA hurdle for its antiviral Galidesivir. This milestone accelerates the path toward pivotal animal studies and potential FDA approval under the Animal Rule.
Victor Sage
Victor Sage
31 Aug 2026

Browse the archive

Full archive